Polypharmacy in assisted living and impact on clinical outcomes

Barbara Resnick, Elizabeth Galik, Marie Boltz, Sarah Holmes, Steven Fix, Erin Vigne, Shijun Zhu, Regina Lewis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVE: The purpose of this study was to describe medication use and polypharmacy in assisted living settings. We hypothesized that: 1) age, gender, race, setting, multimorbidity, and cognitive status would influence polypharmacy; and 2) polypharmacy would be associated with falls, emergency room visits, and hospitalizations. DESIGN: This was a descriptive study using data from a larger study testing the Dissemination and Implementation of Function Focused Care for Assisted Living (FFC-AL-EIT). SETTING: Participants were recruited from 26 assisted living settings. PARTICIPANTS: A total of 242 individuals for cohort 1 consented and completed baseline data collection. INTERVENTIONS: Data were obtained from participant medical records, observations, and input from staff. MAIN OUTCOME MEASURE(S): Age, gender, race, ethnicity, comorbidities, cognitive status, medications, falls, emergency room visits, hospitalizations, function based on the Barthel Index and physical activity using the MotionWatch 8. RESULTS: Participants had a mean age of 86.86 (standard deviation [SD] = 7.0), the majority were women (n = 179, 74%) and white (n = 233, 96%), with five (SD = 2) diagnoses. The mean number of drugs was seven (SD = 3.56), and 51% were exposed to polypharmacy. The mean Barthel Index score was 63.06 (SD = 20.20), and they engaged in 111,353 (SD = 87,262) counts of activity daily. Fifty-eight residents fell at least once (24%), 22 were sent to the hospital (9%), and 32 (13%) to the emergency room. Neither hypothesis was supported. CONCLUSION: Continued research is needed to explore the factors that influence polypharmacy. Identification of these factors will help guide deprescribing so that medication management does not harm older adults physically or cause unnecessary financial burden.

Original languageEnglish (US)
Pages (from-to)321-330
Number of pages10
JournalConsultant Pharmacist
Volume33
Issue number6
DOIs
StatePublished - Jun 2018

Fingerprint

Polypharmacy
Hospital Emergency Service
Comorbidity
Hospitalization
Medical Records
Exercise
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Resnick, B., Galik, E., Boltz, M., Holmes, S., Fix, S., Vigne, E., ... Lewis, R. (2018). Polypharmacy in assisted living and impact on clinical outcomes. Consultant Pharmacist, 33(6), 321-330. https://doi.org/10.4140/TCP.n.2018.321
Resnick, Barbara ; Galik, Elizabeth ; Boltz, Marie ; Holmes, Sarah ; Fix, Steven ; Vigne, Erin ; Zhu, Shijun ; Lewis, Regina. / Polypharmacy in assisted living and impact on clinical outcomes. In: Consultant Pharmacist. 2018 ; Vol. 33, No. 6. pp. 321-330.
@article{5772adfa78f64002b830b764bdbde9d0,
title = "Polypharmacy in assisted living and impact on clinical outcomes",
abstract = "OBJECTIVE: The purpose of this study was to describe medication use and polypharmacy in assisted living settings. We hypothesized that: 1) age, gender, race, setting, multimorbidity, and cognitive status would influence polypharmacy; and 2) polypharmacy would be associated with falls, emergency room visits, and hospitalizations. DESIGN: This was a descriptive study using data from a larger study testing the Dissemination and Implementation of Function Focused Care for Assisted Living (FFC-AL-EIT). SETTING: Participants were recruited from 26 assisted living settings. PARTICIPANTS: A total of 242 individuals for cohort 1 consented and completed baseline data collection. INTERVENTIONS: Data were obtained from participant medical records, observations, and input from staff. MAIN OUTCOME MEASURE(S): Age, gender, race, ethnicity, comorbidities, cognitive status, medications, falls, emergency room visits, hospitalizations, function based on the Barthel Index and physical activity using the MotionWatch 8. RESULTS: Participants had a mean age of 86.86 (standard deviation [SD] = 7.0), the majority were women (n = 179, 74{\%}) and white (n = 233, 96{\%}), with five (SD = 2) diagnoses. The mean number of drugs was seven (SD = 3.56), and 51{\%} were exposed to polypharmacy. The mean Barthel Index score was 63.06 (SD = 20.20), and they engaged in 111,353 (SD = 87,262) counts of activity daily. Fifty-eight residents fell at least once (24{\%}), 22 were sent to the hospital (9{\%}), and 32 (13{\%}) to the emergency room. Neither hypothesis was supported. CONCLUSION: Continued research is needed to explore the factors that influence polypharmacy. Identification of these factors will help guide deprescribing so that medication management does not harm older adults physically or cause unnecessary financial burden.",
author = "Barbara Resnick and Elizabeth Galik and Marie Boltz and Sarah Holmes and Steven Fix and Erin Vigne and Shijun Zhu and Regina Lewis",
year = "2018",
month = "6",
doi = "10.4140/TCP.n.2018.321",
language = "English (US)",
volume = "33",
pages = "321--330",
journal = "The Senior care pharmacist",
issn = "2639-9636",
publisher = "American Society of Consultant Pharmacists",
number = "6",

}

Resnick, B, Galik, E, Boltz, M, Holmes, S, Fix, S, Vigne, E, Zhu, S & Lewis, R 2018, 'Polypharmacy in assisted living and impact on clinical outcomes', Consultant Pharmacist, vol. 33, no. 6, pp. 321-330. https://doi.org/10.4140/TCP.n.2018.321

Polypharmacy in assisted living and impact on clinical outcomes. / Resnick, Barbara; Galik, Elizabeth; Boltz, Marie; Holmes, Sarah; Fix, Steven; Vigne, Erin; Zhu, Shijun; Lewis, Regina.

In: Consultant Pharmacist, Vol. 33, No. 6, 06.2018, p. 321-330.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Polypharmacy in assisted living and impact on clinical outcomes

AU - Resnick, Barbara

AU - Galik, Elizabeth

AU - Boltz, Marie

AU - Holmes, Sarah

AU - Fix, Steven

AU - Vigne, Erin

AU - Zhu, Shijun

AU - Lewis, Regina

PY - 2018/6

Y1 - 2018/6

N2 - OBJECTIVE: The purpose of this study was to describe medication use and polypharmacy in assisted living settings. We hypothesized that: 1) age, gender, race, setting, multimorbidity, and cognitive status would influence polypharmacy; and 2) polypharmacy would be associated with falls, emergency room visits, and hospitalizations. DESIGN: This was a descriptive study using data from a larger study testing the Dissemination and Implementation of Function Focused Care for Assisted Living (FFC-AL-EIT). SETTING: Participants were recruited from 26 assisted living settings. PARTICIPANTS: A total of 242 individuals for cohort 1 consented and completed baseline data collection. INTERVENTIONS: Data were obtained from participant medical records, observations, and input from staff. MAIN OUTCOME MEASURE(S): Age, gender, race, ethnicity, comorbidities, cognitive status, medications, falls, emergency room visits, hospitalizations, function based on the Barthel Index and physical activity using the MotionWatch 8. RESULTS: Participants had a mean age of 86.86 (standard deviation [SD] = 7.0), the majority were women (n = 179, 74%) and white (n = 233, 96%), with five (SD = 2) diagnoses. The mean number of drugs was seven (SD = 3.56), and 51% were exposed to polypharmacy. The mean Barthel Index score was 63.06 (SD = 20.20), and they engaged in 111,353 (SD = 87,262) counts of activity daily. Fifty-eight residents fell at least once (24%), 22 were sent to the hospital (9%), and 32 (13%) to the emergency room. Neither hypothesis was supported. CONCLUSION: Continued research is needed to explore the factors that influence polypharmacy. Identification of these factors will help guide deprescribing so that medication management does not harm older adults physically or cause unnecessary financial burden.

AB - OBJECTIVE: The purpose of this study was to describe medication use and polypharmacy in assisted living settings. We hypothesized that: 1) age, gender, race, setting, multimorbidity, and cognitive status would influence polypharmacy; and 2) polypharmacy would be associated with falls, emergency room visits, and hospitalizations. DESIGN: This was a descriptive study using data from a larger study testing the Dissemination and Implementation of Function Focused Care for Assisted Living (FFC-AL-EIT). SETTING: Participants were recruited from 26 assisted living settings. PARTICIPANTS: A total of 242 individuals for cohort 1 consented and completed baseline data collection. INTERVENTIONS: Data were obtained from participant medical records, observations, and input from staff. MAIN OUTCOME MEASURE(S): Age, gender, race, ethnicity, comorbidities, cognitive status, medications, falls, emergency room visits, hospitalizations, function based on the Barthel Index and physical activity using the MotionWatch 8. RESULTS: Participants had a mean age of 86.86 (standard deviation [SD] = 7.0), the majority were women (n = 179, 74%) and white (n = 233, 96%), with five (SD = 2) diagnoses. The mean number of drugs was seven (SD = 3.56), and 51% were exposed to polypharmacy. The mean Barthel Index score was 63.06 (SD = 20.20), and they engaged in 111,353 (SD = 87,262) counts of activity daily. Fifty-eight residents fell at least once (24%), 22 were sent to the hospital (9%), and 32 (13%) to the emergency room. Neither hypothesis was supported. CONCLUSION: Continued research is needed to explore the factors that influence polypharmacy. Identification of these factors will help guide deprescribing so that medication management does not harm older adults physically or cause unnecessary financial burden.

UR - http://www.scopus.com/inward/record.url?scp=85048927274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048927274&partnerID=8YFLogxK

U2 - 10.4140/TCP.n.2018.321

DO - 10.4140/TCP.n.2018.321

M3 - Article

C2 - 29880094

AN - SCOPUS:85048927274

VL - 33

SP - 321

EP - 330

JO - The Senior care pharmacist

JF - The Senior care pharmacist

SN - 2639-9636

IS - 6

ER -